Chargement en cours...
Dexmedetomidine improves cardiac function and protects against maladaptive remodeling following myocardial infarction
Dexmedetomidine (DEX), a highly specific and selective α2 adrenergic receptor agonist, has been demonstrated to possess potential cardioprotective effects. However, the mechanisms underlying this process remain to be fully illuminated. In the present study, a myocardial infarction (MI) animal model...
Enregistré dans:
| Publié dans: | Mol Med Rep |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6854534/ https://ncbi.nlm.nih.gov/pubmed/31661145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10774 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|